Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2013

01.05.2013 | Original Article

The Fatty Acid Profile of the Erythrocyte Membrane in Initial-Onset Inflammatory Bowel Disease Patients

verfasst von: Kan Uchiyama, Shunichi Odahara, Makoto Nakamura, Shigeo Koido, Kiyohiko Katahira, Hiromi Shiraishi, Toshifumi Ohkusa, Kiyotaka Fujise, Hisao Tajiri

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Background and Objectives

The sudden change in the dietary habits of the Japanese population towards a European/American-style diet since the 1960s is thought to be responsible for the recent increase in the incidence of inflammatory bowel disease (IBD) in Japan. Dietary fatty acid intake influences the fatty acid profiles of vital cell membranes, which might be a source of inflammatory mediators.

Methods

We investigated the fatty acid composition of the erythrocyte membrane in 90 healthy Japanese and 43 initial-onset IBD patients (ulcerative colitis, UC: 25; Crohn’s disease, CD: 18) who had not undergone any dietary intervention to examine the role fatty acids play in the onset of IBD.

Results

The erythrocyte membrane n-3/n-6 ratio of the initial-onset IBD patients was 0.42 ± 0.13, which was not significantly different from that of the healthy Japanese subjects (0.41 ± 0.13). However, the CD patients displayed a significantly lower mean percentage weight (MPW) of linoleic acid (LA) than the healthy subjects (8.25 ± 1.75 vs. 9.90 ± 1.29; p < 0.001), while their MPW of arachidonic acid (AA) was significantly higher than those of the healthy subjects and UC patients (11.22 ± 2.18 vs. 9.76 ± 1.64, p < 0.01; vs. 9.58 ± 1.97, p < 0.01, respectively). The mean delta 6-desaturation index of the CD patients was significantly higher than that of the healthy subjects (1.61 ± 0.65 vs. 1.11 ± 0.26; p < 0.001).

Conclusions

The CD patients displayed significantly higher and lower MPW of AA and LA, respectively, than the healthy subjects, suggesting that delta 6-desaturase is hyperactivated in CD. The cell membrane fatty acid profile might be a therapeutic target in CD.
Literatur
1.
Zurück zum Zitat Adachi H, Hino A. Trends in nutritional intake and serum cholesterol levels over 40 years in Tanushimaru, Japanese men. J Epidemiol. 2005;15:85–89.PubMedCrossRef Adachi H, Hino A. Trends in nutritional intake and serum cholesterol levels over 40 years in Tanushimaru, Japanese men. J Epidemiol. 2005;15:85–89.PubMedCrossRef
2.
Zurück zum Zitat Igarashi O, Sugano M, Ikeda I. A Modern Viewpoint of the Fatty Acid Nutrition. Tokyo, Koseikan: Japanese Society of Nutrition and Food Science; 1998 (in Japanese). Igarashi O, Sugano M, Ikeda I. A Modern Viewpoint of the Fatty Acid Nutrition. Tokyo, Koseikan: Japanese Society of Nutrition and Food Science; 1998 (in Japanese).
3.
Zurück zum Zitat Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.PubMedCrossRef Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.PubMedCrossRef
4.
Zurück zum Zitat Economou M, Pappas G. New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–720.PubMedCrossRef Economou M, Pappas G. New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–720.PubMedCrossRef
5.
Zurück zum Zitat Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7:260–270.PubMedCrossRef Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7:260–270.PubMedCrossRef
6.
Zurück zum Zitat Yang SK, Hong WS, Min TI, et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986–1997. J Gastroenterol Hepatol. 2000;15:1037–1042.PubMedCrossRef Yang SK, Hong WS, Min TI, et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986–1997. J Gastroenterol Hepatol. 2000;15:1037–1042.PubMedCrossRef
7.
Zurück zum Zitat Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn’s disease in Chinese population. Inflamm Bowel Dis. 2004;10:646–651.PubMedCrossRef Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn’s disease in Chinese population. Inflamm Bowel Dis. 2004;10:646–651.PubMedCrossRef
8.
Zurück zum Zitat Abdul-Baki H, ElHajj I, El-Zahabi LM, et al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2007;13:475–480.PubMedCrossRef Abdul-Baki H, ElHajj I, El-Zahabi LM, et al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2007;13:475–480.PubMedCrossRef
9.
Zurück zum Zitat Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn’s disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 1999;94:2961–2965.PubMedCrossRef Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn’s disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 1999;94:2961–2965.PubMedCrossRef
10.
Zurück zum Zitat Tanaka C, Kato R. New Pharmacology. 2nd ed. Tokyo: Nankodo; 1994 (in Japanese). Tanaka C, Kato R. New Pharmacology. 2nd ed. Tokyo: Nankodo; 1994 (in Japanese).
11.
Zurück zum Zitat Okuyama H. Cancers as inflammatory disease caused by excessive intake of linoleic acid. Environ Mutagen Res. 2003;25:147–157.CrossRef Okuyama H. Cancers as inflammatory disease caused by excessive intake of linoleic acid. Environ Mutagen Res. 2003;25:147–157.CrossRef
12.
Zurück zum Zitat van-Hees PAM, Bakker JH, van Tongeren JHM. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moietry of sulphasalazine. Gut. 1980;21:632–635.PubMedCrossRef van-Hees PAM, Bakker JH, van Tongeren JHM. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moietry of sulphasalazine. Gut. 1980;21:632–635.PubMedCrossRef
13.
Zurück zum Zitat The IBD in EPIC Study Investigators. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested cases–control study within a European prospective cohort study. Gut. 2009;58:1606–1611.CrossRef The IBD in EPIC Study Investigators. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested cases–control study within a European prospective cohort study. Gut. 2009;58:1606–1611.CrossRef
14.
Zurück zum Zitat Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids-The n-6/n-3 balance and chronic elderly disease. Prog Lipid Res. 1997;35:409–457.CrossRef Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids-The n-6/n-3 balance and chronic elderly disease. Prog Lipid Res. 1997;35:409–457.CrossRef
15.
Zurück zum Zitat Saku N, Kobayashi J, Kitamura S. Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages activated by silica. Prostaglandins Leukot Essent Fatty Acids. 1999;61:51–54.PubMedCrossRef Saku N, Kobayashi J, Kitamura S. Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages activated by silica. Prostaglandins Leukot Essent Fatty Acids. 1999;61:51–54.PubMedCrossRef
16.
Zurück zum Zitat Uchiyama K, Nakamura M, Odahara S, et al. n-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1696–1707.PubMedCrossRef Uchiyama K, Nakamura M, Odahara S, et al. n-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1696–1707.PubMedCrossRef
17.
Zurück zum Zitat Dodge JT, Michelle C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963;100:119–130.PubMedCrossRef Dodge JT, Michelle C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 1963;100:119–130.PubMedCrossRef
18.
Zurück zum Zitat Ohta A, Mayo MC, Kramer N, Lands WE. Rapid analysis of fatty acids in plasma lipids. Lipids. 1990;25:742–747.PubMedCrossRef Ohta A, Mayo MC, Kramer N, Lands WE. Rapid analysis of fatty acids in plasma lipids. Lipids. 1990;25:742–747.PubMedCrossRef
19.
Zurück zum Zitat Sharon P, Stenson WF. Enhanced synthesis of leukotriene B by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984;86:453–460.PubMed Sharon P, Stenson WF. Enhanced synthesis of leukotriene B by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984;86:453–460.PubMed
20.
Zurück zum Zitat Shimizu T, Fujii T, Suzuki R, et al. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2003;37:581–585.PubMedCrossRef Shimizu T, Fujii T, Suzuki R, et al. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2003;37:581–585.PubMedCrossRef
21.
Zurück zum Zitat Almallah YZ, El-Tahir A, Heys SD, Richardson S, Eremin O. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58–65.PubMedCrossRef Almallah YZ, El-Tahir A, Heys SD, Richardson S, Eremin O. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58–65.PubMedCrossRef
22.
Zurück zum Zitat Almallah YZ, Ewen SW, El-Tahir A, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol. 2000;20:68–76.PubMedCrossRef Almallah YZ, Ewen SW, El-Tahir A, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J Clin Immunol. 2000;20:68–76.PubMedCrossRef
23.
Zurück zum Zitat Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn’s disease patients. Dig Dis Sci. 1994;39:2589–2594.PubMedCrossRef Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn’s disease patients. Dig Dis Sci. 1994;39:2589–2594.PubMedCrossRef
24.
Zurück zum Zitat Lands WE, Libelt B, Morris A, et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta. 1992;1180:147–162.PubMedCrossRef Lands WE, Libelt B, Morris A, et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta. 1992;1180:147–162.PubMedCrossRef
25.
Zurück zum Zitat Diet Intake Standards in Japanese Established by the Ministry of Health, Labour and Welfare. Tokyo: Daiichi Shuppan; 2005 (in Japanese). Diet Intake Standards in Japanese Established by the Ministry of Health, Labour and Welfare. Tokyo: Daiichi Shuppan; 2005 (in Japanese).
26.
Zurück zum Zitat Nakamura M. Nutritional therapy in inflammatory bowel disease—dietary plan based on food exchange lists and evaluation of n-3 polyunsaturated fatty acids. Tokyo Jikeikai Med J. 2000;115:297–313 (in Japanese). Nakamura M. Nutritional therapy in inflammatory bowel disease—dietary plan based on food exchange lists and evaluation of n-3 polyunsaturated fatty acids. Tokyo Jikeikai Med J. 2000;115:297–313 (in Japanese).
27.
Zurück zum Zitat Glaz JFC, Soffers AEMF, Karan MB. Fatty acid composition of serum cholesterol esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989;49:269–276. Glaz JFC, Soffers AEMF, Karan MB. Fatty acid composition of serum cholesterol esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989;49:269–276.
28.
Zurück zum Zitat Ma J, Folsom AR, Shahar E, Eckfeldt JH. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr. 1995;62:564–571.PubMed Ma J, Folsom AR, Shahar E, Eckfeldt JH. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr. 1995;62:564–571.PubMed
29.
Zurück zum Zitat Subbaiah PV, Kaufman D, Bagdade JD. Incorporation of dietary n-3 fatty acid into molecular species of phosphatidyl choline and cholesterol ester in normal human plasma. Am J Clin Nutr. 1993;58:360–368.PubMed Subbaiah PV, Kaufman D, Bagdade JD. Incorporation of dietary n-3 fatty acid into molecular species of phosphatidyl choline and cholesterol ester in normal human plasma. Am J Clin Nutr. 1993;58:360–368.PubMed
30.
Zurück zum Zitat Leikin AI, Brenner R. Fatty acid desaturase activities are modulated by phytosterol incorporation in microsomes. Biochim Biophys Acta. 1989;1005:187–191.PubMedCrossRef Leikin AI, Brenner R. Fatty acid desaturase activities are modulated by phytosterol incorporation in microsomes. Biochim Biophys Acta. 1989;1005:187–191.PubMedCrossRef
31.
Zurück zum Zitat Lans WEM. Fish and Human Health. New York, NY: Academic Press; 1986. Lans WEM. Fish and Human Health. New York, NY: Academic Press; 1986.
Metadaten
Titel
The Fatty Acid Profile of the Erythrocyte Membrane in Initial-Onset Inflammatory Bowel Disease Patients
verfasst von
Kan Uchiyama
Shunichi Odahara
Makoto Nakamura
Shigeo Koido
Kiyohiko Katahira
Hiromi Shiraishi
Toshifumi Ohkusa
Kiyotaka Fujise
Hisao Tajiri
Publikationsdatum
01.05.2013
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2013
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2508-6

Weitere Artikel der Ausgabe 5/2013

Digestive Diseases and Sciences 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.